Mylan has completed the acquisition of Meda and the company is now a controlled subsidiary of Mylan. “Meda opens up a number of new opportunities for us, such as significantly expanding our over-the-counter presence into a $1 billion business. Additionally, Meda accelerates our expansion in attractive emerging markets, such as China, Southeast Asia, Russia and the Middle East, and provides us opportunities to maximize our efficient, high quality operating platform and broad product portfolio”, said Mylan president Rajiv Malik.